Literature DB >> 18991861

Antagonist of M1 muscarinic acetylcholine receptor prevents neurotoxicity induced by amphetamine via nitric oxide pathway.

Valentina Bashkatova1, Ariane Hornick, Anatoly Vanin, Helmut Prast.   

Abstract

The psychostimulant amphetamine (AMPH) has been found to induce striatal acetylcholine release and neurotoxic processes via nitric oxide (NO) and lipid peroxidation (LPO). Our purpose was to determine whether blocking striatal muscarinic (M1) receptors by the selective M1 antagonist toxin 7 (MT 7; bilaterally, 2 microg per side) might attenuate the effects of AMPH (4 x 5 mg/kg, i.p.). Systemic AMPH administration increased NO and LPO in the striatal tissue. Stimulation of M1 receptors by i.c.v. injection of M1 agonist McN-A-343 (200 microg) caused a similar enhancement of NO and LPO. Pretreatment with the MT7 prevented the AMPH-induced NO generation and greatly reduced the LPO caused by the psychostimulant. These results show that M1 acetylcholine receptors are critically involved in neurotoxic processes induced by AMPH via NO and LPO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991861     DOI: 10.1196/annals.1432.004

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  M1 and M3 muscarinic receptors may play a role in the neurotoxicity of anhydroecgonine methyl ester, a cocaine pyrolysis product.

Authors:  Raphael Caio Tamborelli Garcia; Livia Mendonça Munhoz Dati; Larissa Helena Torres; Mariana Aguilera Alencar da Silva; Mariana Sayuri Berto Udo; Fernando Maurício Francis Abdalla; José Luiz da Costa; Renata Gorjão; Solange Castro Afeche; Mauricio Yonamine; Colleen M Niswender; P Jeffrey Conn; Rosana Camarini; Maria Regina Lopes Sandoval; Tania Marcourakis
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

2.  Possible mechanisms involved in the vasorelaxant effect produced by clobenzorex in aortic segments of rats.

Authors:  J Lozano-Cuenca; A González-Hernández; O A López-Canales; J R Villagrana-Zesati; J D Rodríguez-Choreão; R Morín-Zaragoza; E F Castillo-Henkel; J S López-Canales
Journal:  Braz J Med Biol Res       Date:  2017-08-07       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.